MobileODT, a maker of portable, smart, connected medical devices to enable health providers to reach every patient, everywhere, raised an additional $6.825m in Series B funding.
The round was led by OrbiMed Advisors with participation from previous investor Tristel plc. As a part of the new financing, Dr. Ron Ginor, a Venture Partner at OrbiMed Advisors, will join the MobileODT Board of Directors.
The company, which has raised over $13 million to date, plans to use the funds to continue to expand its product portfolio and IP as well as grow sales and marketing efforts in the US and international markets in which it is currently selling.
Led by Ariel Beery, CEO & Chairman of the Board, MobileODT develops portable, smart, connected medical devices to enable health providers to reach patients, everywhere.
The first product, the FDA cleared EVA System, is being used across 43 health systems in the United States, and by public and private providers in 26 countries around the world for cervical cancer screening and diagnosis, and forensic colposcopy for sexual assault examinations.